341 related articles for article (PubMed ID: 23456446)
1. Role of microangiopathy in diabetic cardiomyopathy.
Adameova A; Dhalla NS
Heart Fail Rev; 2014 Jan; 19(1):25-33. PubMed ID: 23456446
[TBL] [Abstract][Full Text] [Related]
2. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and diabetic cardiomyopathy: a brief review.
Cai L; Kang YJ
Cardiovasc Toxicol; 2001; 1(3):181-93. PubMed ID: 12213971
[TBL] [Abstract][Full Text] [Related]
4. Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.
Mortuza R; Chakrabarti S
Heart Fail Rev; 2014 Jan; 19(1):75-86. PubMed ID: 23430126
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
6. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.
Wang D; Luo P; Wang Y; Li W; Wang C; Sun D; Zhang R; Su T; Ma X; Zeng C; Wang H; Ren J; Cao F
Diabetes; 2013 May; 62(5):1697-708. PubMed ID: 23364453
[TBL] [Abstract][Full Text] [Related]
8. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.
Frati G; Schirone L; Chimenti I; Yee D; Biondi-Zoccai G; Volpe M; Sciarretta S
Cardiovasc Res; 2017 Mar; 113(4):378-388. PubMed ID: 28395009
[TBL] [Abstract][Full Text] [Related]
9. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
[TBL] [Abstract][Full Text] [Related]
10. Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy.
Kandula V; Kosuru R; Li H; Yan D; Zhu Q; Lian Q; Ge RS; Xia Z; Irwin MG
Cardiovasc Diabetol; 2016 Mar; 15():44. PubMed ID: 26956801
[TBL] [Abstract][Full Text] [Related]
11. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
Falcão-Pires I; Leite-Moreira AF
Heart Fail Rev; 2012 May; 17(3):325-44. PubMed ID: 21626163
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of changes of myocardial angiogenesis and energy metabolism in postinfarction and diabetic damage of rat heart.
Afanasiev SA; Egorova MV; Kondratyeva DS; Batalov RE; Popov SV
J Diabetes Res; 2014; 2014():827896. PubMed ID: 24689068
[TBL] [Abstract][Full Text] [Related]
13. Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
Evangelista I; Nuti R; Picchioni T; Dotta F; Palazzuoli A
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269778
[TBL] [Abstract][Full Text] [Related]
14. Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium Signaling.
Smani T; Gallardo-Castillo I; Ávila-Médina J; Jimenez-Navarro MF; Ordoñez A; Hmadcha A
Curr Med Chem; 2019; 26(22):4166-4177. PubMed ID: 28545369
[TBL] [Abstract][Full Text] [Related]
15. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
16. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
17. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
Mahmoud AM
Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
[TBL] [Abstract][Full Text] [Related]
19. Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling.
Lal N; Chiu AP; Wang F; Zhang D; Jia J; Wan A; Vlodavsky I; Hussein B; Rodrigues B
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1163-H1175. PubMed ID: 28314760
[TBL] [Abstract][Full Text] [Related]
20. Diabetic cardiomyopathy and oxidative stress: role of antioxidants.
Thandavarayan RA; Giridharan VV; Watanabe K; Konishi T
Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):225-30. PubMed ID: 21902660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
